Impact of next generation sequencing on our understanding of CAKUT.


Journal

Seminars in cell & developmental biology
ISSN: 1096-3634
Titre abrégé: Semin Cell Dev Biol
Pays: England
ID NLM: 9607332

Informations de publication

Date de publication:
07 2019
Historique:
received: 25 12 2017
revised: 16 08 2018
accepted: 28 08 2018
pubmed: 2 9 2018
medline: 28 4 2020
entrez: 2 9 2018
Statut: ppublish

Résumé

Congenital abnormalities of the kidney and urinary tract (CAKUT) form the leading cause of pediatric end-stage renal disease. Knowledge on the molecular mechanisms that underlie CAKUT leads to the improvement of DNA diagnostics and counseling regarding prognosis and recurrence risk estimation for CAKUT patients and their relatives. Implementation of next generation sequencing in research and diagnostic settings has led to the identification of the molecular basis of many developmental diseases. In this review, we summarize the efforts on next generation sequencing in CAKUT research and we discuss how next generation sequencing added to our understanding of CAKUT genetics. Although next generation sequencing has certainly proven to be a game changer in the field of disease gene identification and novel CAKUT-causing gene variants have been identified, most CAKUT cases still remain unsolved. Occurring with genetic and phenotypic heterogeneity along with incomplete penetrance, the identification of CAKUT etiology poses many challenges. We see great potential for combined -omics approaches that include next generation sequencing in the identification of CAKUT-specific biomarkers, which is necessary to optimize the care for CAKUT patients.

Identifiants

pubmed: 30172048
pii: S1084-9521(17)30604-3
doi: 10.1016/j.semcdb.2018.08.013
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104-110

Informations de copyright

Copyright © 2018. Published by Elsevier Ltd.

Auteurs

Anukrati Nigam (A)

Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, P.O.Box 85060, 3508 AB, Utrecht, The Netherlands.

Nine V A M Knoers (NVAM)

Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, P.O.Box 85060, 3508 AB, Utrecht, The Netherlands. Electronic address: v.v.a.knoers@umcutrecht.nl.

Kirsten Y Renkema (KY)

Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, P.O.Box 85060, 3508 AB, Utrecht, The Netherlands.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH